688265.SH
南模生物
SSE · Healthcare · Biotechnology · CN
CNY 40.03
−5.37%Margins
Gross margin
52.8%
EBITDA margin
19.5%
EBIT margin
7.6%
Net margin
7.6%
FCF margin
5.4%
1.9%
Return on equity
1.7%
Return on assets
1.9%
Return on invested capital
0.22x
Asset turnover
CNY 88.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026